Effect of the SARS-CoV-2 Delta-associated G15U mutation on the s2m element dimerization and its interactions with miR-1307-3p
暂无分享,去创建一个
J. Evanseck | M. Mihailescu | Patrick E. Lackey | Patrick E Lackey | Adam H. Kensinger | Joseph A. Makowski | Caylee L. Cunningham | Morgan Shine | Caleb J. Frye | Joseph A Makowski | Adam H Kensinger | Ella J. Milback
[1] I. Rouzina,et al. Structural domains of SARS-CoV-2 nucleocapsid protein coordinate to compact long nucleic acid substrates , 2022, Nucleic acids research.
[2] G. Grant,et al. microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model , 2022, ACS omega.
[3] J. Evanseck,et al. Structural, Dynamical, and Entropic Differences between SARS-CoV and SARS-CoV-2 s2m Elements Using Molecular Dynamics Simulations , 2022, ACS physical chemistry Au.
[4] A. Leitner,et al. A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2 , 2022, bioRxiv.
[5] J. Evanseck,et al. Bioinformatics analysis of the s2m mutations within the SARS‐CoV‐2 Omicron lineages , 2022, Journal of medical virology.
[6] Abhishek S. Rao,et al. MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies , 2022, Life Sciences.
[7] R. Granek,et al. Managing an evolving pandemic: Cryptic circulation of the Delta variant during the Omicron rise , 2022, Science of The Total Environment.
[8] P. Fournier,et al. A 21L/BA.2-21K/BA.1 “MixOmicron” SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis , 2022, Infection, Genetics and Evolution.
[9] S. Gharbia,et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.
[10] F. Kirchhoff,et al. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? , 2022, Journal of virology.
[11] Frances E. Muldoon,et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.
[12] D. Peaper,et al. Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons , 2022, Med.
[13] Robert G. Brinson,et al. Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p , 2021, Nucleic acids research.
[14] Dandan Tian,et al. The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape , 2021, Frontiers in Immunology.
[15] E. Campbell,et al. Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design , 2021, Nature reviews. Molecular cell biology.
[16] E. Klein,et al. Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals , 2021, medRxiv.
[17] Vineet D. Menachery,et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant , 2021, bioRxiv.
[18] C. Lorson,et al. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses , 2021, Journal of Autoimmunity.
[19] Y. Liu,et al. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus , 2021, Journal of travel medicine.
[20] R. Gibbs,et al. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections , 2021, BMC Medicine.
[21] W. Scott,et al. Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome , 2021, Journal of virology.
[22] L. Lipovich,et al. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery , 2021, Non-coding RNA.
[23] Thi H. O. Nguyen,et al. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection , 2021, PLoS pathogens.
[24] K. Machida,et al. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection , 2021, Journal of Biological Chemistry.
[25] A. Elfiky,et al. SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses , 2020, Frontiers in Pharmacology.
[26] J. Qiu,et al. The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region , 2020, Viruses.
[27] N. Schork,et al. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets , 2020, mSphere.
[28] K. Saxena,et al. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy , 2020, Nucleic acids research.
[29] Samira Mahmoudi,et al. Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors , 2020, Informatics in Medicine Unlocked.
[30] Opeyemi S. Soremekun,et al. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells , 2020, Informatics in Medicine Unlocked.
[31] T. Yeh,et al. Emerging viral mutants in Australia suggest RNA recombination event in the SARS‐CoV‐2 genome , 2020, The Medical journal of Australia.
[32] G. Grant,et al. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities , 2020, Viruses.
[33] G. Gao,et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 , 2020, Journal of Allergy and Clinical Immunology.
[34] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[35] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[36] K. Kim,et al. What Is COVID-19? , 2020, Frontiers for Young Minds.
[37] J. Hageman. The Coronavirus Disease 2019 (COVID-19). , 2020, Pediatric annals.
[38] Ibrahim M. Ibrahim,et al. COVID-19 spike-host cell receptor GRP78 binding site prediction , 2020, Journal of Infection.
[39] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[40] C. Peng,et al. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..
[41] S. Bernacchi,et al. Retroviral RNA Dimerization: From Structure to Functions , 2018, Front. Microbiol..
[42] Stefan Elbe,et al. Data, disease and diplomacy: GISAID's innovative contribution to global health , 2017, Global challenges.
[43] William B. Klimstra,et al. MicroRNA Regulation of RNA Virus Replication and Pathogenesis , 2016, Trends in Molecular Medicine.
[44] T. Tengs,et al. Distribution and Evolutionary History of the Mobile Genetic Element s2m in Coronaviruses , 2016, Diseases.
[45] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[46] C. Di Primo,et al. Mutations of the SL2 dimerization sequence of the hepatitis C genome abrogate viral replication , 2015, Cellular and Molecular Life Sciences.
[47] Raphael Gottardo,et al. Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.
[48] H. Shimoda,et al. Emergence of Pathogenic Coronaviruses in Cats by Homologous Recombination between Feline and Canine Coronaviruses , 2014, PloS one.
[49] J. Steitz,et al. Virus Meets Host MicroRNA: the Destroyer, the Booster, the Hijacker , 2014, Molecular and Cellular Biology.
[50] S. L. Le Grice,et al. In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader , 2013, Nucleic acids research.
[51] T. Tengs,et al. A mobile genetic element with unknown function found in distantly related viruses , 2013, Virology Journal.
[52] R. Gorelick,et al. Molecular determinants of HIV-1 NCp7 chaperone activity in maturation of the HIV-1 dimerization initiation site , 2012, Nucleic acids research.
[53] S. Lemon,et al. Stabilization of hepatitis C virus RNA by an Ago2–miR-122 complex , 2012, Proceedings of the National Academy of Sciences.
[54] B. Cullen,et al. Viruses, microRNAs, and host interactions. , 2010, Annual review of microbiology.
[55] S. Lemon,et al. Hepatitis C virus genomic RNA dimerization is mediated via a kissing complex intermediate. , 2010, RNA.
[56] Jianbo Chen,et al. Probing the HIV-1 Genomic RNA Trafficking Pathway and Dimerization by Genetic Recombination and Single Virion Analyses , 2009, PLoS pathogens.
[57] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[58] R. Wartell,et al. Conversion of stable RNA hairpin to a metastable dimer in frozen solution. , 2007, RNA.
[59] Jialing Huang,et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.
[60] Ryan Cook,et al. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. , 2007, Immunity.
[61] Xianglan Li,et al. An efficient thermally induced RNA conformational switch as a framework for the functionalization of RNA nanostructures. , 2006, Journal of the American Chemical Society.
[62] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[63] A. Saïb,et al. A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.
[64] D. Haussler,et al. The Structure of a Rigorously Conserved RNA Element within the SARS Virus Genome , 2004, PLoS biology.
[65] J. Greatorex. The retroviral RNA dimer linkage: different structures may reflect different roles , 2004, Retrovirology.
[66] M. Mihailescu,et al. A proton-coupled dynamic conformational switch in the HIV-1 dimerization initiation site kissing complex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[67] F. Pedersen,et al. Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions. , 2004, Virology.
[68] Ben Berkhout,et al. Dimerization and Template Switching in the 5′ Untranslated Region between Various Subtypes of Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.
[69] J. Marino,et al. Mechanism of nucleocapsid protein catalyzed structural isomerization of the dimerization initiation site of HIV-1. , 2002, Biochemistry.
[70] Ben Berkhout,et al. In Vitro Evidence That the Untranslated Leader of the HIV-1 Genome Is an RNA Checkpoint That Regulates Multiple Functions through Conformational Changes* , 2002, The Journal of Biological Chemistry.
[71] F. Pedersen,et al. Mutations of the Kissing-Loop Dimerization Sequence Influence the Site Specificity of Murine Leukemia Virus Recombination In Vivo , 2000, Journal of Virology.
[72] C. Ehresmann,et al. The crystal structure of the dimerization initiation site of genomic HIV-1 RNA reveals an extended duplex with two adenine bulges. , 1999, Structure.
[73] P. Simmonds,et al. Mosaic Structure of the Human Immunodeficiency Virus Type 1 Genome Infecting Lymphoid Cells and the Brain: Evidence for Frequent In Vivo Recombination Events in the Evolution of Regional Populations , 1999, Journal of Virology.
[74] L. Williams,et al. Melting of a DNA hairpin without hyperchromism. , 1998, Biochemistry.
[75] B. Roques,et al. NCp7 Activates HIV-1Lai RNA Dimerization by Converting a Transient Loop-Loop Complex into a Stable Dimer* , 1996, The Journal of Biological Chemistry.
[76] B. Berkhout,et al. Role of the DIS hairpin in replication of human immunodeficiency virus type 1 , 1996, Journal of virology.
[77] T. Vial,et al. Immune-mediated side-effects of cytokines in humans. , 1995, Toxicology.
[78] J. Darlix,et al. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus. , 1994, Journal of molecular biology.
[79] V. Saudek,et al. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.
[80] K. Crandall,et al. The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.
[81] D. Draper,et al. Melting studies of RNA unfolding and RNA-ligand interactions. , 1995, Methods in enzymology.